Dealmakers: Robert Grossman, Ira Rosner and Joshua Samek
The Deal: The Greenberg Traurig shareholders led a large team of attorneys who represented Opko Health Inc. in its $1.47 billion acquisition of Bio-Reference Laboratories Inc.
Opko, a Miami-based biopharmaceutical and diagnostics company founded by billionaire health entrepreneur Dr. Phillip Frost, and Elmwood Park, New Jersey-based Bio-Reference reached an agreement June 3, and the deal was completed Aug. 20.
Details: Under terms announced in June, Opko offered 2.75 shares of its common stock for each share of Bio-Reference stock, or $52.58 based on Opko's June 3 closing price of $19.12.
Continue Reading. (subscription required)